NAGE

ChromaDex Corporation (NASDAQ:CDXC) is a bioscience company founded in 1999 and headquartered in Los Angeles, California. The company specializes in healthy aging research and is a leader in the development of nicotinamide adenine dinucleotide (NAD) precursor technologies. ChromaDex went public in 2015 and has evolved from a contract research organization into a consumer health company focused on NAD boosting supplements and potential pharmaceutical applications. The company is known for its proprietary ingredient Niagen and its consumer brand TRU NIAGEN, which targets the growing market of consumers interested in longevity and cellular health optimization.